Abstract
Despite improved overall survival rates after potentially curative liver resection (∼50-58% at 5 years), almost half of patients experience disease recurrence highlighting the need for a precise definition of outcomes to stratify patients for clinical trials and to guide treatment decisions. In the past, several factors, such as an advanced primary T stage, the primary N+ status, a large tumor size, multiple tumors, a disease-free interval of
Original language | English |
---|---|
Pages (from-to) | 45-57 |
Number of pages | 13 |
Journal | Future Oncology |
Volume | 9 |
Issue number | 1 |
DOIs | |
Publication status | Published - Jan 2013 |
Keywords
- colorectal cancer
- hepatectomy
- liver metastases
- prognosis
- survival
- tumor recurrence
ASJC Scopus subject areas
- Oncology
- Cancer Research